1 |
The
SQuID
protocol (subcutaneous insulin in diabetic ketoacidosis): Impacts on
ED
operational metrics
|
|
|
| Richard T. Griffey, Ryan M. Schneider, Margo Girardi, Julianne Yeary, Craig McCammon, Laura Frawley, Rachel Ancona, Paulina Cruz-Bravo |
|
| Academic Emergency Medicine. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Clinical and biochemical predictors of intensive care unit admission among patients with diabetic ketoacidosis |
|
|
| Adeel Ahmad Khan, Fateen Ata, Phool Iqbal, Mohammed Bashir, Anand Kartha |
|
| World Journal of Diabetes. 2023; 14(3): 271 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis |
|
|
| Kareema S Alshurtan, Osama Alnizari, Hadi Aldarwish , Ali A Al-Tufaif |
|
| Cureus. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis |
|
|
| Priya Rao, Sheng-fang Jiang, Patricia Kipnis, Divyesh M. Patel, Svetlana Katsnelson, Samineh Madani, Vincent X. Liu |
|
| JAMA Network Open. 2022; 5(4): e226417 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Management of hospitalized patients with mild to moderate diabetic ketoacidosis using a continuous insulin infusion protocol on a medical surgical ward and observation level of care: A retrospective cohort study |
|
|
| Michael S. Yoo, Abraham Daniels, Rene A. Maslow, John A. Gomez, Nannette L. Meyers, Pamela S. Bohrer, Siamack Nemazie, Christina E. Sanford, Emily A. Peterson, Kendal L. Hamann, Darcy E. Walsh, Alison M. O’Herlihy, Vivek Kumra |
|
| Medicine. 2022; 101(31): e29665 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Subcutaneous Rapid-acting Insulin Analogs for Diabetic Ketoacidosis |
|
|
| Lillian Chow, Walter Valesky, Shahriar Zehtabchi |
|
| Academic Emergency Medicine. 2021; 28(6): 700 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Acidose métabolique |
|
|
| Audrey De Jong, Joris Pensier, Boris Jung, Fouad Belafia, Gérald Chanques, Samir Jaber |
|
| Anesthésie & Réanimation. 2021; 7(1): 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Use of a Flexible Catheter for the Administration of Subcutaneous Insulin in Diabetic Ketoacidosis: A Feasibility Controlled Clinical Trial |
|
|
| Maria Laura Beaudoin, Milagros Torrents, María Florencia Tittarelli, Magali Hamui, Mariano Ibarra, Mabel Ferraro, Juan Pablo Ferreira |
|
| Hospital Pediatrics. 2021; 11(4): 396 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Outcomes of diabetic ketoacidosis in a tertiary centre with restricted
intensive care unit
bed capacity
|
|
|
| Iftach Sagy, Noa Zimhony-Nissim, Evgenia Brandstaetter, Inna Lipnitzki, Hadeel Musa, Yakov Rosen, Leonid Barski |
|
| Internal Medicine Journal. 2021; 51(6): 948 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of
COVID
-19 and resource-limited settings-role of subcutaneous insulin
|
|
|
| Leena Priyambada, Joseph I. Wolfsdorf, Stuart J. Brink, Maria Fritsch, Ethel Codner, Kim C. Donaghue, Maria E. Craig |
|
| Pediatric Diabetes. 2020; 21(8): 1394 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison |
|
|
| Kota Vidyasagar, Boya Chandrasekar, Manik Chhabra, Anil Bhansali, Dipika Bansal |
|
| Clinical Therapeutics. 2020; 42(8): e115 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Diabetic ketoacidosis |
|
|
| Ketan K. Dhatariya, Nicole S. Glaser, Ethel Codner, Guillermo E. Umpierrez |
|
| Nature Reviews Disease Primers. 2020; 6(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway |
|
|
| Karli Edholm, Katie Lappé, Polina Kukhareva, Christy Hopkins, Nathan D. Hatton, Benjamin Gebhart, Heather Nyman, Emily Signor, Mikyla Davis, Kensaku Kawamoto, Stacy A. Johnson |
|
| Journal for Healthcare Quality. 2020; 42(5): e66 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations |
|
|
| Nadine E Palermo, Archana R Sadhu, Marie E McDonnell |
|
| The Journal of Clinical Endocrinology & Metabolism. 2020; 105(8): 2819 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis |
|
|
| Carlos A Andrade-Castellanos, Luis Enrique Colunga-Lozano, Netzahualpilli Delgado-Figueroa, Daniel A Gonzalez-Padilla |
|
| Cochrane Database of Systematic Reviews. 2016; 2016(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Question 1: Treatment of mild to moderate ketoacidosis in children and adolescents with subcutaneous insulin |
|
|
| D. Mul,E. Molendijk |
|
| Archives of Disease in Childhood. 2015; 100(1): 106 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Evaluation of Ward Management of Diabetic Ketoacidosis |
|
|
| Branden D. Nemecek, Kathie L. Hermayer, Pamela C. Arnold, Nicole M. Bohm |
|
| Clinical Diabetes. 2014; 32(3): 100 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: A review of the current evidence from clinical studies |
|
|
| M. Vincent,E. Nobécourt |
|
| Diabetes & Metabolism. 2013; 39(4): 299 |
|
| [Pubmed] [Google Scholar] [DOI] |
|